The freshest news traversing many of the major institutions, researchers' and activists’ accounts on Twitter is the recent release of a docu-series based on writer Michael Pollan’s 2018 book “How To Change Your Mind: What the science of psychedelics teaches us about consciousness, dying, addiction, depression, and transcendence.”
Some of those tweeting about the recent trailer release were renowned mycologist and entrepreneur Paul Stamets, MAPS founder Rick Doblin, Numinus NUMIF founder Payton Nyquvest, chief medical officer of Awakn Life Sciences AWKNF Dr. Ben Sessa and director of Psychedelics Division at Imperial College London Robin Carhart-Harris.
The trailer for #HowToChangeYourMind is officially here! This is one of @netflix's newest docu series about psychedelics based on the best-selling book by author @michaelpollan. Excited to share there will be an episode (#2) dedicated to psilocybin history and therapy! pic.twitter.com/uZVo27bStB— Paul Stamets (@PaulStamets) June 16, 2022
The publication, indebted to a 2015 article Pollan wrote about psychedelic psychotherapy for The New Yorker in which he interviewed cancer patients who had taken guided sessions on psilocybin, received high acclaim from the scientific world, the general audience and many critics, such as The New York Times Book Review, The Guardian and The Boston Globe.
The book explores the renaissance of scientific research into psychedelic compounds and their potential to relieve various types of mental suffering, while also surfing into the history of psychedelics in the United States.
Pollan interviewed neuroscientists using psychedelics in conjunction with modern brain imaging technologies to probe the mysteries of consciousness and the self. By the time he finished writing, he was absolutely transformed by what he had learned.
“This book has taken me places I’ve never been—indeed, places I didn’t know existed,” Pollan said.
The first chapter of the documentary will be released on Netflix NFLX on July 12. In the meantime, check out the trailer!
Photo Courtesy of Kyle Loftus on Pexels.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.
All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.
Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.
Rate collection and criteria: Click here for more information on rate collection and criteria.